dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:17:59Z
dc.date.available2014-05-27T11:17:59Z
dc.date.created2014-05-27T11:17:59Z
dc.date.issued1995-01-01
dc.identifierRevista da Sociedade Brasileira de Medicina Tropical, v. 28, n. 3, p. 233-236, 1995.
dc.identifier0037-8682
dc.identifierhttp://hdl.handle.net/11449/64556
dc.identifier10.1590/S0037-86821995000300011
dc.identifierS0037-86821995000300011
dc.identifier2-s2.0-0029121176
dc.identifier2-s2.0-0029121176.pdf
dc.description.abstractIn this study the immunopotentiator levamisole as well as a mixture of BCG/Mycobacterium leprae were investigated in inactive lepromatous leprosy patients by using the Mitsuda reaction as a parameter. Twenty lepromatous patients ten years ago classified as histologically negative for Mitsuda's test were divided into three groups: five patients that were only retested with Mitsuda antigen; eight patients that received oral levamisol and seven patients that received a mixture of alive BCG plus autoclaved M. leprae. The results indicated that: 1) the levamisole did not alter the reactivity to lepromin in any of the patients studied; 2) neither the changes in the reactivity to lepromin by using the mixture (3 cases) nor those that occurred spontaneously (3 cases) were clear. They properly reflected the natural variation of patients with some degree of resistance to Mycobacterium leprae.
dc.languagepor
dc.relationRevista da Sociedade Brasileira de Medicina Tropical
dc.relation1.358
dc.relation0,658
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectBCG/Mycobacterium leprae
dc.subjectimmunotherapy
dc.subjectleprosy
dc.subjectlevamisole
dc.subjectbcg vaccine
dc.subjectbacterial vaccine
dc.subjectBCG vaccine
dc.subjectimmunological adjuvant
dc.subjectclinical article
dc.subjecthistology
dc.subjecthuman
dc.subjectimmunomodulation
dc.subjectmycobacterium leprae
dc.subjectclinical trial
dc.subjectcontrolled clinical trial
dc.subjectcontrolled study
dc.subjectimmunology
dc.subjectMycobacterium leprae
dc.subjectAdjuvants, Immunologic
dc.subjectBacterial Vaccines
dc.subjectBCG Vaccine
dc.subjectHumans
dc.subjectImmunotherapy
dc.subjectLeprosy
dc.subjectLevamisole
dc.titleAVALIACAO DA REACAO DE MITSUDA EM PACIENTES VIRCHOVIANOS INATIVOS ANTES E APOS IMUNOTERAPIA
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución